Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Navin Suthahar, Wouter C. Meijers, Herman H.W. Silljé, et al.
Theranostics (2017) Vol. 8, Iss. 3, pp. 593-609
Open Access | Times Cited: 267

Showing 1-25 of 267 citing articles:

Heart failure with preserved ejection fraction: from mechanisms to therapies
Carolyn S.P. Lam, Adriaan A. Voors, Rudolf A. de Boer, et al.
European Heart Journal (2018) Vol. 39, Iss. 30, pp. 2780-2792
Open Access | Times Cited: 298
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
Rudolf A. de Boer, Gilles W. De Keulenaer, Johann Bauersachs, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 3, pp. 272-285
Open Access | Times Cited: 240
Galectin-3 in Cardiovascular Diseases
Valeria Blanda, Umberto Marcello Bracale, Maria Donata Di Taranto, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9232-9232
Open Access | Times Cited: 162
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
Wouter C. Meijers, Antoni Bayés‐Genís, Alexandre Mebazaa, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1610-1632
Open Access | Times Cited: 117
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 53
The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
Beata Zaborska, Małgorzata Sikora-Frąc, Krzysztof Smarż, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13111-13111
Open Access | Times Cited: 48
PREDICTION OF INTERSTITIAL LUNG DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS PATIENTS: A COHORT STUDY ANALYSIS
D. Khorolskii, ALESYA A. KLIMENKO, Е. С. Першина, et al.
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 2, pp. 79-84
Open Access | Times Cited: 18
HIV- AND TUBERCULOSIS-ASSOCIATED PERICARDITIS
Е. А. Бородулина, K. Zhilinskaya, DANIIL A. TALAGAEV, et al.
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 2, pp. 91-97
Open Access | Times Cited: 18
The role of galectins in virus infection - A systemic literature review
Wen‐Hung Wang, Chih-Yen Lin, Max R. Chang, et al.
Journal of Microbiology Immunology and Infection (2019) Vol. 53, Iss. 6, pp. 925-935
Open Access | Times Cited: 129
Galectin-3 Is a Potential Mediator for Atherosclerosis
Ziyu Gao, Zhongni Liu, Rui Wang, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 101
Galectin–Carbohydrate Interactions in Biomedicine and Biotechnology
Dominic Laaf, Pavla Bojarová, Lothar Elling, et al.
Trends in biotechnology (2018) Vol. 37, Iss. 4, pp. 402-415
Closed Access | Times Cited: 94
Extracellular and intracellular small-molecule galectin-3 inhibitors
John Stegmayr, Fredrik R. Zetterberg, Michael C. Carlsson, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 92
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du, Arnold Piek, Elisabeth M. Schouten, et al.
Theranostics (2018) Vol. 8, Iss. 15, pp. 4155-4169
Open Access | Times Cited: 84
Sex‐related differences in contemporary biomarkers for heart failure: a review
Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 5, pp. 775-788
Open Access | Times Cited: 83
Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease
Yinyin Tan, Yanqun Zheng, Daiwen Xu, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 73
The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
Grażyna Sygitowicz, Agata Maciejak, Dariusz Sitkiewicz
Biomolecules (2021) Vol. 12, Iss. 1, pp. 46-46
Open Access | Times Cited: 65
Chronic low‐grade inflammation in heart failure with preserved ejection fraction
Thássio Mesquita, Yen‐Nien Lin, Ahmed Ibrahim
Aging Cell (2021) Vol. 20, Iss. 9
Open Access | Times Cited: 58
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Arantxa González, Mark Richards, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 927-943
Open Access | Times Cited: 52
Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot
Yànhuá Lǐ, Tian Li, Zhiguang Zhou, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 3, pp. 569-577
Open Access | Times Cited: 39
Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades
Xiaoyin Wang, Meenakshi Gaur, Khalid Mounzih, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 15, pp. 2536-2549
Open Access | Times Cited: 23
A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis
Seyed Sobhan Bahreiny, Akram Ahangarpour, Mojtaba Aghaei, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 1621-1633
Closed Access | Times Cited: 10
Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases
William DeGroat, Habiba Abdelhalim, Elizabeth Peker, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Long non-coding RNA XR008038 promotes the myocardial ischemia/reperfusion injury development through increasing the expressions of galectin-3
Meiqi Zhang, Qilan Chen, Kang Cheng, et al.
International Journal of Cardiology (2025) Vol. 422, pp. 132955-132955
Closed Access | Times Cited: 1
Galectins and Liver Diseases
Shima Mimura, Asahiro Morishita, Kyoko Oura, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 790-790
Open Access | Times Cited: 1
Sarcopenic obesity and the risk of atrial fibrillation in non-diabetic older adults: a prospective cohort study
Xinyi Yu, Jianying Chao, Xin Wang, et al.
Clinical Nutrition (2025) Vol. 47, pp. 282-290
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top